Renegade.bio, Metabolomic Diagnostics to Develop Preeclampsia Risk Screening Test for US Market

Renegade.bio, Metabolomic Diagnostics to Develop Preeclampsia Risk Screening Test for US Market

Source

360Dx

Date

February 15, 2022